Multiresistant Stenotrophomonas maltophilia tunneled CVC-related sepsis, treated with systemic and lock therapy

Journal of Chemotherapy

Volumn 16, Issue 5, 2004, Pages 494-496

  Gattuso, G ^a   Tomasoni, D ^a   Ceruti, R ^a   Scalzini, A ^a  

^a CARLO POMA HOSPITAL   (Italy)

Author keywords

Fluoroquinolones; Gram negative bacterial infection; Lock therapy; Sepsis; Stenotrophomonas maltophilia

Indexed keywords

ACETYLSALICYLIC ACID; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GLYCOPEPTIDE; LEVOFLOXACIN; PREDNISONE; SULFAMETHOXAZOLE; TEICOPLANIN; TRIMETHOPRIM;

ADULT; ANAMNESIS; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CASE REPORT; CENTRAL VENOUS CATHETER; CHEMOTHERAPY; CLINICAL PRACTICE; GRAM NEGATIVE SEPSIS; HOSPITAL INFECTION; HUMAN; MALE; MULTIDRUG RESISTANCE; NASOPHARYNX CARCINOMA; STENOTROPHOMONAS MALTOPHILIA; SYSTEMIC THERAPY;

EID: 8544252403     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.5.494     Document Type: Article

References (13)

1. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002; 34: 634-40.
2. Giamarellou H. Prescribing guidelines for severe Pseudomonas infections. J Antimicrob Chemother 2002; 49(2): 229-33.
3. Sanyal SC, Mokaddas EM. The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen. J Chemother 1999; 11 (1): 28-33.
4. Ratnalingham RA, Peckham D, Denton M, Kerr K, Conway S. Stenotrophomonas maltophilia bacteremia in two patients with cystic fibrosis associated with totally implantable venous access devices. J Infect 2002; 44 (1): 53-5.
5. Friedman ND, Korman TM, Fairley CK, Franklin JC, Spelman DW. Bacteremia due to Stenotrophomonas maltophilia: analysis of 45 episodes. J Infect 2002; 45 (1): 47-53.
6. Benoit JL, Caradang G, Sitrin M, Arnow PM. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis 1995; 21: 1286-8.
7. Micozzi A, Venditti M, Monaco M, Martino P et al. Bacteriemia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 2000; 31 (3): 705-11.
8. Edmond MB, Fallace SE, McClish DJ et al. Nosocomial Bloodstream Infections in the US Hospitals: a three years analysis. Clin Infect Dis 1999; 29: 239-44.
9. Centers for Disease Control and Prevention. NNIS System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 2000; 28: 429-35.
10. Wenzel RP. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 1995; 20: 1531-4.
11. Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis 2002; 34: 1653-6.
12. Viale PL, Pagani L, Petrosillo N, Gattuso G et al (for Italian Hospital and HIV Infection Group). Antibiotic lock-technique for the treatment of catheter-related bloodstream infections. J Chemother 2003; 15(2): 152-6.
13. Gaillard JL, Merlino R, Pajot N et al. Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. J Parenter Enteral Nutr 1990; 14: 593-7.